The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFragrant Prosp. Regulatory News (FPP)

  • This share is currently suspended. It was suspended at a price of 0.516

Share Price Information for Fragrant Prosp. (FPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.516
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.516
FPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on Intended Acquisition

8 Mar 2022 11:55

RNS Number : 0418E
Fragrant Prosperity Holdings Ltd
08 March 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WITHIN, INTO OR IN THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, THE REPUBLIC OF IRELAND OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. 

 

Fragrant Prosperity Holdings Limited

 

("FPP" or the "Company")

 

 

Update on Intended Acquisition

 

 

Further to its statement on 24 May 2021, the Company announces that discussions with CiiTECH about a planned reverse takeover of the Company, (the "RTO" or "Intended Acquisition") have ceased. The exclusivity period agreed between the parties in their letter of intent expired on 31 October 2021, since when it has not been possible to conclude a combination of the two businesses.

 

Simon Retter, Chairman, said:

"The Board will continue to evaluate potential transactions in line with its strategy to invest in innovative technologies with high growth potential in the fintech, health care and health care therapeutics sectors."

 

Clifton Flack, Founder and CEO of CiiTECH, said:

"The transaction faced a number of challenges as we worked with various groups of shareholders to agree a deal. Movements in equity capital markets have been volatile, not least driven by geopolitical uncertainty. CiiTECH has therefore decided to withdraw from the process.

 

"CiiTECH continues to grow its business as its main markets emerge from the pandemic and we implement our strategy for the business. We remain optimistic for the future of the business and are exploring a range of options to sustainably finance the company.

 

"We thank FPP's board for its efforts and wish them every success in pursuing other opportunities."

 

The company is in the process of putting a request in to the FCA for the shares to be restored and it is expected that the Company's ordinary shares will resume trading on the Main Market of the London Stock Exchange in due course. In the meantime, they remain suspended from trading.

A further announcement will be made as appropriate in due course.

Shareholders and potential target companies should note that the recent change to the Listing Rules announced by the FCA in December 2021 that imposed a minimum market capitalisation of £30m on companies coming to the Official List does not apply to FPP in relation to its first reverse takeover, provided that it makes a complete submission to the FCA for an eligibility review for listing and a prospectus review relating to that reverse takeover which does not lapse and is not withdrawn, prior to 4pm on 1 December 2023. The Company will therefore, following a reverse takeover, be eligible to re-list with a market capitalisation of £700,000 or more provided that it meets that timeframe.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement this information is considered to be in the public domain.

 

- Ends -

 

 

Enquiries

Fragrant Prosperity Holdings Limited

Simon Retter

 

+44 (0)20 3137 1902

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQJPMBTMTIMBLT
Date   Source Headline
28th Mar 20247:01 amRNSFinal Results
22nd Nov 20233:00 pmRNSStatement re. Suspension
23rd Mar 202311:27 amRNSStatement re. Suspension
16th Mar 20237:01 amRNSHolding(s) in Company
16th Mar 20237:00 amRNSHolding(s) in Company
13th Mar 20237:00 amRNSHolding(s) in Company
10th Mar 20237:00 amRNSHolding(s) in Company
8th Mar 20232:48 pmRNSHolding(s) in Company
8th Mar 20237:00 amRNSHolding(s) in Company
6th Mar 20237:00 amRNSHolding(s) in Company
3rd Mar 20237:00 amRNSHolding(s) in Company
28th Feb 20233:17 pmRNSHolding(s) in Company
2nd Feb 20232:30 pmRNSHolding(s) in Company
26th Jan 20238:21 amRNSHolding(s) in Company
23rd Jan 20232:12 pmRNSHolding(s) in Company
29th Dec 20224:49 pmRNSHalf-year Report
30th Sep 20221:39 pmRNSAnnual Financial Report
3rd May 202212:55 pmRNSHolding(s) in Company
3rd May 202211:19 amRNSHolding(s) in Company
3rd May 202211:00 amRNSHolding(s) in Company
3rd May 202210:59 amRNSHolding(s) in Company
5th Apr 20222:39 pmRNSHolding(s) in Company
25th Mar 20224:22 pmRNSHolding(s) in Company
25th Mar 202212:55 pmRNSHolding(s) in Company
25th Mar 20227:00 amRNSHolding(s) in Company
24th Mar 20227:01 amRNSStmnt re Share Price Movement
24th Mar 20227:00 amRNSHolding(s) in Company
24th Mar 20227:00 amRNSHolding(s) in Company
23rd Mar 20221:38 pmRNSHolding(s) in Company
23rd Mar 20229:05 amRNSSecond Price Monitoring Extn
23rd Mar 20229:00 amRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSHolding(s) in Company
11th Mar 20224:37 pmRNSHolding(s) in Company
9th Mar 20222:06 pmRNSSecond Price Monitoring Extn
9th Mar 20222:00 pmRNSPrice Monitoring Extension
9th Mar 20229:05 amRNSSecond Price Monitoring Extn
9th Mar 20229:00 amRNSPrice Monitoring Extension
8th Mar 20224:23 pmRNSRestoration of Listing
8th Mar 202211:55 amRNSUpdate on Intended Acquisition
1st Feb 20227:00 amRNSHalf-year Report
13th Jan 202212:21 pmRNSResult of AGM
16th Dec 20217:00 amRNSNotice of AGM
7th Dec 20212:40 pmRNSCiiTECH transaction and LR5 notification
7th Dec 20217:00 amRNSIssue of Debt
10th Nov 20212:20 pmRNSChange of Director
30th Sep 20217:00 amRNSAnnual Financial Report
29th Jul 20214:48 pmRNSRepayment & Issue of Convertible Loan Notes
6th Jul 20218:04 amRNSUpdate on Intended Acquisition
24th May 20217:35 amRNSIntended Acquisition and Suspension of Listing
24th May 20217:30 amRNSSuspension - Fragrant Prosperity Holdings Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.